Mitsubishi UFJ Capital

Mitsubishi UFJ Capital, established in 1974, is a Tokyo-based venture capital firm. It invests in early-stage companies, primarily in the Japanese market, focusing on sectors such as healthcare, biotech, information technology, and electronics. The firm also engages in investment syndication for Japanese deals. Mitsubishi UFJ Capital was previously known as Diamond Capital.

Nobuyoshi Fukumoto

Managing Director

Muneki Handa

President

Takashi Hasegawa

Managing Director and Head of Investment Group I

Masafumi Houshiyama

Deputy President

Junichi Masuda

Managing Director and Founder

Yasufumi Matsuda

Director and Executive Officer

Shinsuke Sakamoto

Deputy President

Fumio Sugasawa

Director and Executive Officer

Junichi Taguchi

Investment Director

Past deals in 3D Printing

Mjolnir Spaceworks

Series A in 2025
Manufacturer of hybrid rocket engines and propellant tanks designed for mass production of rockets. The company's platform uses solid plastic fuel and a liquid oxidizer, which is extremely safe and simple, enabling significant cost reduction and mass production, enabling consumers to experience the wonders of space travel and creating an era in which anyone can go to space.

Spiral

Seed Round in 2024
Spiral Inc. is a Tokyo-based company founded in 2016 that specializes in designing and manufacturing artificial intelligence-based automated devices, including robots, drones, and satellites. The company offers advanced drone solutions specifically tailored for non-GPS environments, making them suitable for indoor applications in construction sites, warehouses, and factories. Spiral's proprietary technology allows these drones to navigate autonomously, enabling efficient inspection and monitoring of various industrial settings. Additionally, the company manufactures industrial robots aimed at small- and medium-sized enterprises, as well as providing services to the construction sector and commercial retail businesses.

Dendoh

Pre Seed Round in 2022
Dendoh is a company focused on branding and promotion through augmented reality (AR) technology and 3D design. It provides a platform that allows users to create, customize, and manage 3D deformed avatars for use in various Metaverse environments. With an emphasis on accessibility, Dendoh's service enables individuals to easily design avatars that can be dressed up and utilized across multiple Metaverse spaces in various file formats. The company's mission centers on populating the digital world with engaging and whimsical avatars, enhancing user experiences in virtual settings.

Holoeyes

Series B in 2019
HoloEyes Inc. is a Tokyo-based company founded in 2016 that specializes in developing virtual reality applications for the medical field. The company's platform allows healthcare professionals to transform CT scan data into three-dimensional images, facilitating better visualization and understanding of medical conditions. By creating a medical VR database from accumulated 3D human body models, HoloEyes aims to enhance surgical planning and diagnosis. The technology enables surgeons to simulate operations in a virtual environment, improving their ability to prepare for complex procedures. HoloEyes is focused on expanding its business and increasing its workforce to further develop its innovative VR healthcare solutions.

Cyfuse Biomedical

Venture Round in 2019
Cyfuse Biomedical K.K. is a biotechnology company based in Tokyo, Japan, that specializes in the research, development, and commercialization of tissue fabrication systems and cell-based products. Founded in 2010, the company offers 3D BioFabrication systems that utilize robotic technology to assemble spheroids into customized 3D shapes, providing innovative solutions for cell delivery in research and therapeutic applications. Cyfuse develops and licenses 3D tissue products for therapeutic use and engages in contract manufacturing for research purposes. The applications of its products include blood vessel grafts for hemodialysis access and coronary artery bypass grafts, cardiac grafts for drug toxicology and myocardial infarction therapy, cartilage grafts for surgical reconstruction, and hepatocyte grafts for drug metabolism studies and hemophilia treatment. Cyfuse Biomedical serves various research and development institutes, including universities, and has established a strategic partnership with Shibuya Kogyo Co., Ltd.

Kyoto Robotics

Venture Round in 2019
Kyoto Robotics Corporation is a robotics and automation company based in Kusatsu, Japan, founded in 2000. The company specializes in developing intelligent picking robots tailored for logistics systems, focusing on applications such as palletizing and piece-picking. Kyoto Robotics offers advanced solutions that incorporate a 3D robot vision system capable of object recognition and pose estimation, allowing the robots to intelligently navigate and control their movements. In addition to its robotic products, the company also provides technical support services to ensure effective integration and operation. Formerly known as 3D MEDiA Co., Ltd., Kyoto Robotics adopted its current name in January 2018.

4D Sensor

Venture Round in 2018
4D Sensor specializes in the development, manufacturing, and sale of advanced measurement equipment that captures high-speed, high-precision data related to shape and deformation. Originating from university research, the company focuses on applying innovative technologies to real-world challenges, thereby contributing to societal advancements. Its multi-dimensional scanning technology is designed to accurately measure moving objects and can be utilized in various applications, including production lines with projectors and robots. Additionally, the scanner is capable of dynamically capturing distortions in large structures, such as buildings and bridges, as well as detecting ultra-fine movements. This enables industries to implement precise measurement methods for shape, deformation, and vibration analysis.

Cyfuse Biomedical

Venture Round in 2017
Cyfuse Biomedical K.K. is a biotechnology company based in Tokyo, Japan, that specializes in the research, development, and commercialization of tissue fabrication systems and cell-based products. Founded in 2010, the company offers 3D BioFabrication systems that utilize robotic technology to assemble spheroids into customized 3D shapes, providing innovative solutions for cell delivery in research and therapeutic applications. Cyfuse develops and licenses 3D tissue products for therapeutic use and engages in contract manufacturing for research purposes. The applications of its products include blood vessel grafts for hemodialysis access and coronary artery bypass grafts, cardiac grafts for drug toxicology and myocardial infarction therapy, cartilage grafts for surgical reconstruction, and hepatocyte grafts for drug metabolism studies and hemophilia treatment. Cyfuse Biomedical serves various research and development institutes, including universities, and has established a strategic partnership with Shibuya Kogyo Co., Ltd.

Kyoto Robotics

Venture Round in 2016
Kyoto Robotics Corporation is a robotics and automation company based in Kusatsu, Japan, founded in 2000. The company specializes in developing intelligent picking robots tailored for logistics systems, focusing on applications such as palletizing and piece-picking. Kyoto Robotics offers advanced solutions that incorporate a 3D robot vision system capable of object recognition and pose estimation, allowing the robots to intelligently navigate and control their movements. In addition to its robotic products, the company also provides technical support services to ensure effective integration and operation. Formerly known as 3D MEDiA Co., Ltd., Kyoto Robotics adopted its current name in January 2018.

Cyfuse Biomedical

Venture Round in 2015
Cyfuse Biomedical K.K. is a biotechnology company based in Tokyo, Japan, that specializes in the research, development, and commercialization of tissue fabrication systems and cell-based products. Founded in 2010, the company offers 3D BioFabrication systems that utilize robotic technology to assemble spheroids into customized 3D shapes, providing innovative solutions for cell delivery in research and therapeutic applications. Cyfuse develops and licenses 3D tissue products for therapeutic use and engages in contract manufacturing for research purposes. The applications of its products include blood vessel grafts for hemodialysis access and coronary artery bypass grafts, cardiac grafts for drug toxicology and myocardial infarction therapy, cartilage grafts for surgical reconstruction, and hepatocyte grafts for drug metabolism studies and hemophilia treatment. Cyfuse Biomedical serves various research and development institutes, including universities, and has established a strategic partnership with Shibuya Kogyo Co., Ltd.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.